Resilience of the European health system: proposals from the EU Commission
“We cannot wait for the end of the pandemic to repair and prepare for the future. We will build the foundations of a stronger European...
Hydrogen and electric batteries and the open strategic autonomy of European industry
The concept of “open strategic autonomy” is gaining ground in European policies. It is an idea arising from defence and security policies and which is...
The future of European transport and the decarbonisation challenge
The transport sector is undergoing a period of great change. The traditional concept of mobility has been upset, on the one hand, by the exponential...
Vaccines, how the EU Commission is reorganising to manage the health crisis
Few vaccines, poorly distributed and at prices that are too high for the Member States. In the meantime, the virus continues to spread and European...
I-Com published its Manifesto on Cancer Prevention Strategies and the role of Harm Reduction
Today, 30 November, I-Com published the Manifesto “Innovative solutions with positive impact on healthcare systems and social costs. Unlocking prevention strategies to tackle cancer”, supported...
Vestager meets the European Parliament to discuss the digital market and services
An exchange of views on the new DMA and DSA packages took place on Tuesday February 23 between the EU Commission Executive Vice-President Margrethe Vestager...
Making Europe Safer. A new cybersecurity strategy to build trust and resilience
Digitalisation is revolutionizing business models and the relationship between authorities and citizens and between enterprises and consumers creating new opportunities, but also raising some critical...
The new European Cybersecurity Strategy: objectives and opportunities
The Covid-19 pandemic has made the need for an adequate cyber defense urgent to face the increasing global threats. The fast-growing use of smart working...
Cybersecurity challenges in the EU during the Covid-19 pandemic
Digital platforms in recent years, and overall during the Covid-19 pandemic, have become the privileged space where individuals can carry out their work, social and...
Challenges and opportunities for the development of OMPs in Europe
Orphan Medicinal Products (OMPs) are used for the diagnosis, prevention and treatment of rare diseases. Although their prevalence is less than 5 cases per 10,000...
